Berotralstat hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Berotralstat hydrochloride is an oral plasma kallikrein inhibitor being developed by BioCryst Pharmaceuticals for the treatment of hereditary angioedema (HAE).

Berotralstat hydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Berotralstat hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific		tp@aladdinsci.com	United States	52923	58
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	19956	58
Chongqing jooe co., ltd	+undefined86-15223382610	info@jooe.com	China	15976	58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.	17702719238 18971495150;	sales@sun-shinechem.com	China	1171	64
SHANGHAI FORTUNE CHEMICAL TECHNOLOGY CO., LTD	13816107857	sales@fortunechem-sh.com	China	981	58
Hangzhou J&H Chemical Co., Ltd.	0571-87396432	sales@jhechem.com	China	14916	59
Changzhou Chenhong Biotechnology Co., Ltd.	+86-0519-85788828 +86-13775037613	sales@chemrenpharm.com	China	4058	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24958	58
Shanghai Tachizaki Biomedical Research Center	18014399201	sales@chemlab-tachizaki.com	China	2899	58
Nantong QuanYi Biotechnology Co., Ltd	0513-66337626 18051384581	sales@chemhifuture.com	China	6000	58

---

• Berotralstat hydrochloride
• Berotralstat dihydrochloride
• Berotralstat HCl
• 1809010-52-3